Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia

NCT01206335 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Anorexia
Cancer Cachexia

Interventions

DRUG: OHR/AVR118

Sponsor

Ohr Pharmaceutical Inc.